docfliq
EnglishFrench

FAQs

  • Q. What are the benefits of partnering docfliq for a BioPharma company?

    1. We offer highly effective and bespoke initiatives for KOL and HCP engagement across multiple therapeutic areas:
    2. We engage with over 200 experts globally & 50,000 doctors in multiple geographies within Asia & Africa in segments like Women’s Health, Infertility, Cardio-Metabolic Disorders, Primary Care, Critical Care, Oncology & Rare Diseases through docfliq platform which has strong inbuilt promotion and analytics engine.
    3. We also have preferred partnerships with leading global scientific associations to source & curate latest medical content.
    4. We are therapeutic area agnostic and have multiple case studies to highlight our ability to build a strong HCP community in a new segment/geography within 3 months.
  • Q. How does a scientific association benefit collaborating with docfliq?

    1. We support scientific associations get sponsorships from BioPharma and also improve the reach of the medical content/corporate branding of association in geographies of their interest.
  • Q. I am a medica doctor, how can I collaborate with docfliq?

    1. Please feel free to write to us at support@docfliq.com or call on one of the phone numbers mentioned. We would be glad to have a discussion to take it ahead.
  • Q. Do you have education initiatives for non-doctors healthcare professionals like registered nurses, pharmacists & dieticians?

    1. Yes, we have multiple programs running in different geographies for registered nurses, pharmacists & other healthcare professionals. We can offer a suite of accredited programs as well as KOL-led training modules to suit your requirements.
  • Q. Which countries and languages does docfliq support?

    1. Currently we operate in Middle East Asia, India, and South-East Asia. We have also started some activation in Africa. Most of the currently available content is in English, French or regional Indian languages. However, we also work with experts and scientific societies to generate content in any language of your choice.
  • Q. Can we get exclusivity for projects conducted on docfliq?

    1. We do have preferred collaborations and partners across stakeholders. We endeavor to be a public benefit company and aspire to reach a large audience to continue making significant impact. However, we are open to discuss mutually exclusive projects on a case-by-case basis.
  • Q. Which other products do you have apart from docfliq for HCP engagement?

    1. We have an exciting new product – 3D virtual case study university in pipeline, it will be launched by August 2021. This product will open up new avenues of HCP engagement and medical education. If you are interested to know more about this product, please write to us at support@docfliq.com or contact us at the phone numbers shared in the ‘Contact Us’ section.
    2. If you have an idea for a new product where we can collaborate, please feel free to contact us. We would be glad to share our knowledge & experience.

Still Have A Doubt Or Question?

Contact US